Format

Send to

Choose Destination
Travel Med Infect Dis. 2019 Nov 21:101527. doi: 10.1016/j.tmaid.2019.101527. [Epub ahead of print]

Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure?

Author information

1
Instituto de Microbiologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Electronic address: t.hanscheid@medicina.ulisboa.pt.
2
University of Zürich Travel Clinic, WHO Collaborating Centre for Traveller's Health, Institute for Epidemiology, Biostatistics and Prevention, University of Zürich, Zürich, Switzerland.
3
Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, the Netherlands.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center